25 results
treatment idsa opportunistic prevention diagnosis endocrinology diabetes comparison differential medications inhibitors inotropes mycobacterium nephrology rhabdomyolysis vasopressors abscess acromegaly adrenal agonists
Summary table of mechanism of action, side effect and contraindications of commonly used diabetic drugs. #pharmacology
Summary table of ... #pharmacology #dm2 ... medications #overview #management
Metformin Pharmacology Summary Mechanisms of Action: • Suppresses gluconeogenesis by the liver • Increases insulin-mediated glucose utilization
Metformin Pharmacology ... Summary Mechanisms ... agent • Does not cause ... #Metformin #Pharmacology ... #Summary #DM2 #
GLP-1 Receptor Agonists - Pharmacology Summary Mechanisms of Action: Stimulate glucose-dependent insulin release from the pancreas (GLP-1
Receptor Agonists - Pharmacology ... Summary Mechanisms ... Ozempic), or daily tablet ... not definitively cause ... #Summary #DM2 #
SGLT2 Inhibitors - Pharmacology Summary Mechanisms of Action: Inhibits SGLT2 (sodium/glucose cotransporter 2) in the proximal tubule,
SGLT2 Inhibitors - Pharmacology ... Summary Mechanisms ... Contraindications: eGFR < 30 mL ... hypovolemia) • GU infections ... #Summary #DM2 #
DPP-4 Inhibitors - Pharmacology Summary Mechanisms of Action: Inhibits DPP-4 (dipeptidyl peptidase 4), which normally inactivates GLP-1
4 Inhibitors - Pharmacology ... Summary Mechanisms ... not definitively cause ... DPP4 #Inhibitors #Pharmacology ... #Summary #DM2 #
Vasopressors and Inotropes - Pharmacology Summary Vasopressors Phenylephrine (alpha-1) • Increases BP, SVR • Risk of reflex bradycardia
and Inotropes - Pharmacology ... Summary Vasopressors ... • Higher doses cause ... cAMP/cGMP • Causes ... #Summary #management
Vasopressors Table Rough properties by Target Receptor, Heart Rate/Inotropy, Systemic Vascular Resistance, Cardiac Output, Blood Pressure,
Vasopressors Table ... Resistance, Main Uses ... Vasopressors #Properties #Table ... #Pharmacology # ... Effect #Management
Hemophagocytic Lymphohistiocytosis (HLH) Pathophysiology: Triggering factor (infection,...)→Activation of CD8 T cells (IFN-y) → Excessive activation of macrophages
sIL-2R >2400 Ul/ml ... Drugs, Unknown cause ... Etoposide/VP16 (100 mg/m2 ... Lymphohistiocytosis #diagnosis #management ... #treatment #summary
IDSA Recommendations for Preventing and Treating Penicillium marneffei Infections in HIV-AIDS Preventing 1st Episode of Penicilliosis (Primary
Penicillium marneffei Infections ... 100 cells/mm3 g/mL ... Treating Acute Infection ... Prevention #Treatment #management ... #HIVAIDS #pharmacology
IDSA Recommendations for Preventing and Treating Bacterial Enteric Infections in HIV-AIDS Preventing Bacterial Enteric Illness: • Antimicrobial
Bacterial Enteric Infections ... • In rare cases ... if MIC<0.12 ug/ml ... Prevention #Treatment #management ... #HIVAIDS #pharmacology
No results found for "MCL pharmacology table causes management infections hivaids summary dm2"
Try removing search terms or sorting by relevance
Or Upload an image for you and others searching for #MCL #pharmacology #table #causes #management #infections #hivaids #summary #dm2